Companies to build sales force around lupus drug launch

Human Genome Sciences and GlaxoSmithKline are planning the launch of lupus drug Benlysta, and step one involves building a sales force to call on rheumatologists.

“We'll be able to reach key prescribers with a pretty small, focused bunch,” said Barry Labinger, EVP and chief commercial officer at Human Genome, adding that other sales forces for autoimmune diseases treated by rheumatologists are on the order of 150 reps.  “Certainly we wouldn't need more than that.”

Human Genome and GSK are partners in a 50-50 collaboration on Benlysta, which appears to be emerging from development in fine shape: data from a second Phase III study, released last month, show the drug performed well compared to placebo, with a favorable safety profile.  

Professional messaging, being handled by McCann agency echoTorre Lazur, is likely to key in on Benlysta's ability to meet criteria borne out in the R&D:  proven efficacy and the ability to treat long term without significantly increased safety risk.

The next hurdle is regulatory approval.  Reps could hit the street as soon as the second half of 2010, assuming Human Genome files with FDA early next year and the agency grants priority review.

Barclays Capital's Jim Birchenough expects launch in early 2011, forecasting peak sales of $3 billion. To reach the 200,000 patients Human Genome says are being treated by rheumatologists for the moderate-to-severe form of lupus erythematosus, the companies have tapped online patient groups and are considering social media, but not classic DTC.

 “I don't think we'll be doing mass media DTC,” Labinger said.  “We'll be more targeted.”
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


As US pharma continued its quest for a Grand Prix at the Lions Health international festival of creativity, MM&M went on location to Cannes, France. Missed our coverage from June? Now, we're giving you an opportunity to catch up on some of what you missed. Download our e-book on the two-day festival, recapping the event, rounding up the best of the speakers, offering perspective and listing all of the winners. Click here to download.


The most recent MM&M Skill Sets Live event surveyed a range of issues relating to one of the hottest promotional spaces in healthcare. Speakers and panelists at the morning-long session, including promotional- and multichannel-minded executives from GSK, Epocrates, Treato and Montefiore Medical Center, weighed in on topics designed to help marketers demystify the challenges associated with non-personal promotion. Click here.